Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design.
Daniel-Fischer L, Antlanger M, Cejka D, Eller K, Gauckler P, Odler B, Rudnicki M, Säemann MD, Schmidt A, Sunder-Plassmann G, Wiesholzer M, Windpessl M, Zitt E, Koenig F, Greenbaum LA, Kronbichler A, Aufricht C.
Daniel-Fischer L, et al. Among authors: koenig f.
Kidney Int Rep. 2023 Nov 3;9(2):478-481. doi: 10.1016/j.ekir.2023.10.027. eCollection 2024 Feb.
Kidney Int Rep. 2023.
PMID: 38344717
Free PMC article.
No abstract available.